Bill > HR5629

This bill aims to nullify most of the Department of Health and Human Services' (HHS) final rule on "Medications for the Treatment of Opioid Use Disorder" that was published on February 2, 2024, with one specific exception. The bill will render the entire rule ineffective, except for the portion related to the accreditation standards for opioid treatment programs. By doing so, the legislation effectively blocks the implementation of the HHS rule, which likely involves regulations about medication-assisted treatment for opioid addiction. The exception for accreditation standards suggests that while the bill seeks to prevent the rule from taking effect, it wants to maintain existing guidelines for the operational standards of opioid treatment facilities. This targeted approach indicates a nuanced legislative response to the HHS rule, preserving critical oversight mechanisms while rejecting other aspects of the regulation.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5629/all-info